S. Bossolasco

发表

A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers

A. Lazzarin, P. Cinque, G. Merati, 2017, BMC Infectious Diseases.

Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.

A. Lazzarin, P. Cinque, S. Bossolasco, 2006, Clinical Infectious Diseases.

Ten‐year survival among HIV‐1‐infected subjects with AIDS or non‐AIDS‐defining malignancies

A. Lazzarin, P. Cinque, L. Galli, 2012, International journal of cancer.

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

A. Lazzarin, L. Galli, S. Bossolasco, 2014, AIDS.

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Scientific Reports.

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients.

A. Antinori, P. Cinque, V. Tozzi, 2006, AIDS research and human retroviruses.

The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature

A. Lazzarin, A. Campi, P. Cinque, 2011, Journal of NeuroVirology.

Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?

A. Lazzarin, P. Cinque, C. Fornara, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.

J. Carulli, S. Sunyaev, A. Lazzarin, 2011, The Journal of infectious diseases.

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma

A. Lazzarin, P. Cinque, S. Bossolasco, 2011, Journal of NeuroVirology.

Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain

A. Lazzarin, F. Chiodi, P. Cinque, 2001, AIDS (London).

Central nervous system immune reconstitution disease presenting with vasculitis-like lesions

A. Lazzarin, P. Cinque, S. Bossolasco, 2009 .

Positive predictive value of Epstein-Barr virus DNA detection in HIV-related primary central nervous system lymphoma.

A. Antinori, P. Cinque, A. Cingolani, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

A. Lazzarin, P. Cinque, S. Bossolasco, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2012, AIDS research and treatment.

Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy

C. Yiannoutsos, A. Lazzarin, B. Musick, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.

A. Lazzarin, W. Lüke, P. Cinque, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update.

A. Lazzarin, P. Cinque, S. Bossolasco, 2002, Journal of neurovirology.

Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients.

A. Lazzarin, P. Cinque, S. Bossolasco, 2008, The new microbiologica.

Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance

A. Lazzarin, P. Cinque, S. Bossolasco, 1999, Journal of Neurology Neurosurgery & Psychiatry.

Leishmaniasis Virus-Infected Patients with Visceral Management of Human Immunodeficiency Real-Time PCR Assay for Clinical

A. Lazzarin, P. Cinque, S. Bossolasco, 2003 .

Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization

L. Galli, S. Bossolasco, M. Cernuschi, 2022, Journal of acquired immune deficiency syndromes.

Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system

P. Cinque, Å. Lundkvist, S. Bossolasco, 2002, Journal of Clinical Virology.

OUTCOME OF ACUTE HEPATITIS B VIRUS INFECTION IN HIV-1 INFECTED PATIENTS: POSSIBLE FACTORS ASSOCIATED WITH RESOLUTION OR CHRONICITY

L. Galli, S. Bossolasco, A. Castagna, 2019, Journal of acquired immune deficiency syndromes.

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

A. Lazzarin, P. Cinque, L. Galli, 2015, Journal of the International AIDS Society.

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

A. Lazzarin, P. Cinque, S. Bossolasco, 2011, Journal of NeuroVirology.

Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.

D. Cattaneo, E. Suardi, S. Bossolasco, 2021, AIDS.

Detection of DNA of Lymphotropic Herpesviruses in Plasma of Human Immunodeficiency Virus-Infected Patients: Frequency and Clinical Significance

A. Lazzarin, P. Cinque, S. Bossolasco, 2002, Clinical and Vaccine Immunology.

The application of the polymerase chain reaction of cerebrospinal fluid in the clinical management of AIDS-related CNS disorders.

P. Cinque, S. Bossolasco, B. Giudici, 1998, AIDS patient care and STDs.

Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection

P. Manunta, C. Lanzani, G. Vezzoli, 2021, Journal of Nephrology.

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Clinical Microbiology and Infection.

Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis

A. Lazzarin, P. Cinque, S. Bossolasco, 2003, Journal of Clinical Microbiology.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cerebrospinal fluid HIV‐1 RNA levels: correlation with HIV encephalitis

A. Lazzarin, P. Cinque, S. Bossolasco, 1998, AIDS.

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up.

A. Lazzarin, M. Clementi, L. Galli, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Erratum: Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis (Journal of Clinical Microbiology (2003) 41, 11 (5080-5084))

A. Lazzarin, P. Cinque, S. Bossolasco, 2004 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Predictors of lack of serological response to syphilis treatment in HIV-infected subjects

A. Lazzarin, L. Galli, S. Bossolasco, 2014, Journal of the International AIDS Society.

A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication.

D. Cattaneo, E. Suardi, S. Bossolasco, 2020, Therapeutic drug monitoring.

Retrospective Study On The Outcomes Of Two-drugs Regimens Based On Dolutegravir Plus One Reverse Transcriptase Inhibitor In Virologically Suppressed, HIV-Infected Patients.

A. Lazzarin, P. Cinque, L. Galli, 2020, International journal of antimicrobial agents.

Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV

A. Lazzarin, L. Galli, S. Bossolasco, 2018, Open forum infectious diseases.

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

A. Antinori, P. Cinque, P. Lorenzini, 2011, Journal of NeuroVirology.

Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2.

A. Lazzarin, P. Cinque, S. Bossolasco, 2007, AIDS.

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply.

A. Lazzarin, L. Galli, S. Bossolasco, 2015, AIDS.

Immortal time bias: authors' reply.

A. Lazzarin, L. Galli, S. Bossolasco, 2015, AIDS (London).

Table 1. Diagnoses given to 22 Hiv- Infected Patients Whose Csf Samples Were Positive for Epstein-barr Virus Dna

A. Antinori, A. Cingolani, S. Bossolasco, 2010 .

Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis

A. d’Arminio Monforte, G. Mulé, A. Tavelli, 2023, Pathogens.

Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV

A. Lazzarin, P. Cinque, G. Banfi, 2021, Journal of cachexia, sarcopenia and muscle.

Probable West Nile Virus hepatitis: Case report

S. Bossolasco, M. Cernuschi, A. Castagna, 2023, IDCases.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study

L. Galli, S. Bossolasco, A. Castagna, 2023, Sexually transmitted diseases.

Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.

A. Lazzarin, P. Cinque, S. Bossolasco, 2008, The American journal of tropical medicine and hygiene.